Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24169550 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL24221935 | 0.94 | PTGER4 (0.33) | KDM4EATML3MBTL1PTGER4PDK2 | |
| SCHEMBL17714890 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2RXFP1 | |
| SCHEMBL17714885 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2RXFP1 | |
| SCHEMBL19037015 | 0.93 | KDM4E (0.34) | KDM4EATML3MBTL1PDK2RXFP1 | |
| SCHEMBL19061651 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2RXFP1 | |
| SCHEMBL19061316 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2RXFP1 | |
| SCHEMBL21369655 | 0.92 | PDK2 (0.31) | PDK2RXRARXRB | |
| SCHEMBL17714921 | 0.92 | PTGER4 (0.34) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL17714891 | 0.92 | PTGER4 (0.34) | KDM4EATML3MBTL1PTGER4PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337526-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO.,LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337526-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO.,LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337526-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, LEF1 | KDM4E 2611/4885ATM 2587/4885L3MBTL1 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.